fda compounding semaglutide enforcement october 2025 news restricts non-approved compounded GLP-1 weight loss products Chinese companies turn to generics

Some plans require participation in a specific weight-management programme

Smaller portions are easier to digest and produce less fermentation

Kaiser Wang is a board-certified family medicine physician dedicated to providing comprehensive, personalized care for patients at every stage of life

9 , 1602 (2018) M

In addition to lowering blood sugar and supporting weight loss, semaglutide may reduce the risk of heart attacks and strokes in people with type 2 diabetes and heart disease

Insulin Resistance & Type 2 Diabetes Improves insulin sensitivity in liver and muscle Reduces hepatic glucose output Stabilises blood sugar levels Lowers HbA1c over time This makes retatrutide a disease-modifying option, not just glucose control